94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Med.
Sec. Hepatobiliary Diseases
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1547200
This article is part of the Research Topic Updates in the Pathogenesis and Management of Rejection Post Liver Transplant View all articles
The impact of donor liver fibrosis on the outcomes of patients who undergo liver transplant: A Cohort Study from UNOS database
Provisionally accepted- 1 The University of Hong Kong, Pokfulam, Hong Kong, SAR China
- 2 The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China
The increasing prevalence of fibrosis in donor livers raises concerns about its impact on post-transplantation outcomes, though this relationship remains unclear. This study aims to assess the effect of donor liver fibrosis on patient and graft survival following liver transplantation.Methods: Data from the UNOS-SRTR registry were analyzed, focusing on patients who received liver transplants with biopsy-proven fibrosis. The cohort was stratified based on fibrosis grade, and outcomes were compared using Cox regression and Kaplan-Meier survival analysis. Competing risk models were applied to assess specific causes for graft failure, and subgroup analyses explored the sensitivity of fibrosis on transplant outcomes.Of the 22,897 patients, 17,926 received non-fibrotic grafts, and 4,971 had grafts with varying fibrosis grades. Donor fibrosis was associated with donor age, steatosis, and portal infiltrate, generally affecting those in better overall condition. Significant differences were observed in patient survival (p=0.001) and graft survival (p=0.002) between the fibrosis and non-fibrosis groups. Further analysis revealed that fibrosis increased the risk of malignancy (p=0.028), cardiovascular disease (p=0.017), and respiratory failure (p=0.033), but showed lower rejection rates at six months and one year. Sensitivity analyses confirmed fibrosis as an independent risk factor, with varying effects in subgroups.Donor liver fibrosis significantly impacts post-transplant outcomes, notably increasing the risk of all-cause mortality and graft failure. Specific causes of death, such as malignancy and cardiovascular disease, were more prevalent in recipients of fibrotic grafts, highlighting the need for further research to refine donor selection criteria.
Keywords: Donor fibrosis, Graft failure, Transplant outcome, rejection, Liver Transplantation
Received: 17 Dec 2024; Accepted: 11 Mar 2025.
Copyright: © 2025 Bian, Huang and Zeng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
HanFei Huang, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan Province, China
Zhong Zeng, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.